FR2917087B1 - Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique. - Google Patents

Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Info

Publication number: FR2917087B1
Authority: FR; France
Prior art keywords: thiones; tyrosinase; cosmetics; imidazole; inhibitors
Prior art date: 2007-06-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR0755470A

Other languages

English (en)

Other versions

FR2917087A1 (fr

Inventor

Jean Guy Boiteau

Barbuis Corinne Millois

Sandrine Talano

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Galderma Research and Development SNC

Original Assignee

Galderma Research and Development SNC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-05

Filing date

2007-06-05

Publication date

2012-09-21

2007-06-05 Priority to FR0755470A priority Critical patent/FR2917087B1/fr

2007-06-05 Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC

2008-06-04 Priority to AU2008263666A priority patent/AU2008263666A1/en

2008-06-04 Priority to KR1020097025379A priority patent/KR20100017631A/ko

2008-06-04 Priority to MX2009012712A priority patent/MX2009012712A/es

2008-06-04 Priority to RU2009148791/04A priority patent/RU2009148791A/ru

2008-06-04 Priority to PCT/FR2008/050994 priority patent/WO2008152331A1/fr

2008-06-04 Priority to CA002688235A priority patent/CA2688235A1/fr

2008-06-04 Priority to CN200880018800A priority patent/CN101679296A/zh

2008-06-04 Priority to BRPI0810960-5A2A priority patent/BRPI0810960A2/pt

2008-06-04 Priority to EP08805934A priority patent/EP2155693A1/fr

2008-06-04 Priority to JP2010510856A priority patent/JP2010529096A/ja

2008-06-05 Priority to ARP080102384A priority patent/AR066868A1/es

2008-12-12 Publication of FR2917087A1 publication Critical patent/FR2917087A1/fr

2009-12-04 Priority to US12/631,392 priority patent/US8119674B2/en

2012-09-21 Application granted granted Critical

2012-09-21 Publication of FR2917087B1 publication Critical patent/FR2917087B1/fr

Status Expired - Fee Related legal-status Critical Current

2027-06-05 Anticipated expiration legal-status Critical

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Dermatology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Birds (AREA)
Gerontology & Geriatric Medicine (AREA)
Immunology (AREA)
Pulmonology (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

FR0755470A 2007-06-05 2007-06-05 Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique. Expired - Fee Related FR2917087B1 (fr)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
FR0755470A FR2917087B1 (fr)	2007-06-05	2007-06-05	Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
JP2010510856A JP2010529096A (ja)	2007-06-05	2008-06-04	チロシナーゼ阻害剤として使用される新規の４−フェニルイミダゾール−２−チオン、その調製方法ならびにヒトの医学および化粧品学におけるその使用
MX2009012712A MX2009012712A (es)	2007-06-05	2008-06-04	Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
RU2009148791/04A RU2009148791A (ru)	2007-06-05	2008-06-04	Новые 4-фенилимидазол-2-тионы в качестве ингибиторов тирозиназы, способ их получения и их применение в медицине, а также в косметике
PCT/FR2008/050994 WO2008152331A1 (fr)	2007-06-05	2008-06-04	Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procédé de préparation et leur utilisation en médecine humaine ainsi qu'en cosmétique
CA002688235A CA2688235A1 (fr)	2007-06-05	2008-06-04	Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
AU2008263666A AU2008263666A1 (en)	2007-06-05	2008-06-04	Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
BRPI0810960-5A2A BRPI0810960A2 (pt)	2007-06-05	2008-06-04	"composto, composição farmacêutica, composição cosmética e usos de um composto e de uma composição".
EP08805934A EP2155693A1 (fr)	2007-06-05	2008-06-04	Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procédé de préparation et leur utilisation en médecine humaine ainsi qu'en cosmétique
KR1020097025379A KR20100017631A (ko)	2007-06-05	2008-06-04	타이로시나아제 억제제로서의 신규 4-페닐이미다졸-2-티온, 이의 제조 방법, 및 인간 의약 및 화장품에서의 이의 용도
CN200880018800A CN101679296A (zh)	2007-06-05	2008-06-04	用作酪氨酸酶抑制剂的新型4-苯基-咪唑-2-硫酮、它们的制备方法和它们在人类药物和化妆品中的用途
ARP080102384A AR066868A1 (es)	2007-06-05	2008-06-05	4-fenil-imidazol-2-tionas como inhibidoras de la tirosinasa, su procedimiento de preparacion y su utilizacion en medicina humana como tambien en cosmetica
US12/631,392 US8119674B2 (en)	2007-06-05	2009-12-04	4-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0755470A FR2917087B1 (fr)	2007-06-05	2007-06-05	Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Publications (2)

Publication Number	Publication Date
FR2917087A1 FR2917087A1 (fr)	2008-12-12
FR2917087B1 true FR2917087B1 (fr)	2012-09-21

Family

ID=38468821

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0755470A Expired - Fee Related FR2917087B1 (fr)	2007-06-05	2007-06-05	Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Country Status (13)

Country	Link
US (1)	US8119674B2 (fr)
EP (1)	EP2155693A1 (fr)
JP (1)	JP2010529096A (fr)
KR (1)	KR20100017631A (fr)
CN (1)	CN101679296A (fr)
AR (1)	AR066868A1 (fr)
AU (1)	AU2008263666A1 (fr)
BR (1)	BRPI0810960A2 (fr)
CA (1)	CA2688235A1 (fr)
FR (1)	FR2917087B1 (fr)
MX (1)	MX2009012712A (fr)
RU (1)	RU2009148791A (fr)
WO (1)	WO2008152331A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2917089B1 (fr) *	2007-06-05	2009-07-17	Galderma Res & Dev	Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
FR2916976B1 (fr) *	2007-06-05	2009-09-04	Galderma Res & Dev	Utilisation de 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, pour la preparation de composition pharmaceutiques ou cosmetiques destinees au traitement ou a la prevention des desordres pigmentaires.
FR2939136B1 (fr) *	2008-12-02	2010-12-03	Galderma Res & Dev	Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
TWI619710B (zh) *	2012-07-17	2018-04-01	高雄醫學大學	３－ｐｅｄ４ｈｐｔ衍生物之合成與抗光老化活性之評估

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1206498B (it)	1983-07-18	1989-04-27	Angeli Inst Spa	Derivati amidinici del4-fenilmidazolo 2-sostituto processi per la loro preparazione e loro uso farmaceutico.
US4798843A (en)	1987-07-09	1989-01-17	Smithkline Beckman Corporation	2-mercaproimidazole dopamine-β-hydroxylase inhibitors
JPH05132422A (ja) *	1991-04-09	1993-05-28	Sansho Seiyaku Co Ltd	メラニン生成抑制外用剤
JPH05124923A (ja) *	1991-04-09	1993-05-21	Sansho Seiyaku Co Ltd	メラニン生成抑制外用剤
US7928132B2 (en)	2004-08-06	2011-04-19	Ohio University	Methods for the amelioration of episodes of acute or chronic ulcerative colitis
WO2007039821A2 (fr) *	2005-08-31	2007-04-12	Galderma Research & Development	Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine et dans des cosmetiques
FR2917089B1 (fr) *	2007-06-05	2009-07-17	Galderma Res & Dev	Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

2007
- 2007-06-05 FR FR0755470A patent/FR2917087B1/fr not_active Expired - Fee Related
2008
- 2008-06-04 JP JP2010510856A patent/JP2010529096A/ja active Pending
- 2008-06-04 CN CN200880018800A patent/CN101679296A/zh active Pending
- 2008-06-04 WO PCT/FR2008/050994 patent/WO2008152331A1/fr active Application Filing
- 2008-06-04 EP EP08805934A patent/EP2155693A1/fr not_active Withdrawn
- 2008-06-04 CA CA002688235A patent/CA2688235A1/fr not_active Abandoned
- 2008-06-04 BR BRPI0810960-5A2A patent/BRPI0810960A2/pt not_active IP Right Cessation
- 2008-06-04 KR KR1020097025379A patent/KR20100017631A/ko not_active Application Discontinuation
- 2008-06-04 RU RU2009148791/04A patent/RU2009148791A/ru not_active Application Discontinuation
- 2008-06-04 AU AU2008263666A patent/AU2008263666A1/en not_active Abandoned
- 2008-06-04 MX MX2009012712A patent/MX2009012712A/es active IP Right Grant
- 2008-06-05 AR ARP080102384A patent/AR066868A1/es unknown
2009
- 2009-12-04 US US12/631,392 patent/US8119674B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FR2917087A1 (fr)	2008-12-12
AR066868A1 (es)	2009-09-16
KR20100017631A (ko)	2010-02-16
WO2008152331A1 (fr)	2008-12-18
CA2688235A1 (fr)	2008-12-18
BRPI0810960A2 (pt)	2015-01-27
MX2009012712A (es)	2009-12-08
JP2010529096A (ja)	2010-08-26
AU2008263666A1 (en)	2008-12-18
US20100144814A1 (en)	2010-06-10
WO2008152331A9 (fr)	2009-12-23
RU2009148791A (ru)	2011-07-20
EP2155693A1 (fr)	2010-02-24
US8119674B2 (en)	2012-02-21
CN101679296A (zh)	2010-03-24

Publication	Publication Date	Title
FR2937972B1 (fr)	2013-03-29	Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2937973B1 (fr)	2010-11-05	Modulateurs des recepteurs de la melanocortine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
PH12017502286A1 (en)	2019-11-11	Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
UA109650C2 (xx)	2015-09-25	Біс-арилзв'язані арилтриазолони та їх застосування
FR2939136B1 (fr)	2010-12-03	Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
EA201291336A1 (ru)	2013-04-30	Замещенные 5-фтор-1н-пиразолопиридины и их применение
EP2921177A3 (fr)	2015-12-09	Immunoglobulines à double domaine variable et utilisations de celles-ci
WO2007038459A3 (fr)	2007-07-12	Composes de carboxyamine et leurs methodes d'utilisation
WO2008139122A3 (fr)	2009-02-05	Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
MY169564A (en)	2019-04-22	Substituted dihydropyrazolones and their use
PH12018500641A1 (en)	2019-07-29	Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
WO2012088266A3 (fr)	2012-08-16	Imidazopyridazines et benzimidazoles substitués en tant qu'inhibiteurs de fgfr3
HK1122803A1 (fr)	2009-05-29
FR2961814B1 (fr)	2014-09-26	Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
WO2011026125A3 (fr)	2011-09-29	Compositions pharmaceutiques à rétention gastrique permettant une libération immédiate et prolongée d'acétaminophène
WO2007105015A3 (fr)	2008-03-27	DÉRIVES D'ACIDE 18ß-GLYCYRRHETINIQUE
FR2958163B1 (fr)	2014-06-13	Preparation issue d'une culture in vitro de cellules dedifferencieres non elicitees d'arganier, leur utilisation pour le traitement du vieillissement cutane, de l'inflammation et de la cicatrisation, et leur obtention.
EP2253305A3 (fr)	2014-09-24	Traitement de la peau pour affiner les pores
FR2904557B1 (fr)	2010-04-30	Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques
FR2935380B1 (fr)	2010-09-10	Nouveaux composes hexafluoro-2-biphenyl-isopropanol, modulateurs des recepteurs de type lxrs, leur procede de preparation et leur application comme medicaments en medecine humaine ou veterinaire ainsi qu'en cosmetique.
FR2947268B1 (fr)	2011-08-26	Nouveaux composes benzene-sulfonamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
FR2917087B1 (fr)	2012-09-21	Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
FR2917089B1 (fr)	2009-07-17	Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
FR2937868B1 (fr)	2010-11-05	Composes antagonistes des recepteurs de la melanocortine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2944794B1 (fr)	2012-06-29	Procede de preparation d'oligomeres de glycoside de flavonoide et utilisation en cosmetique.

Legal Events

Date	Code	Title	Description
2014-03-28	ST	Notification of lapse	Effective date: 20140228